POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE)
Clinical trials for POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE) explained in plain language.
Never miss a new study
Get alerted when new POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE) trials appear
Sign up with your email to follow new studies for POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New program aims to keep hospital patients on track for opioid and meth recovery
Disease control OngoingThis study tests a program called MIAPP that adds a patient navigator, smartphone check-ins, and small rewards to usual care for people who start buprenorphine for opioid use in the hospital and also use methamphetamine. The goal is to help them connect to outpatient treatment wi…
Matched conditions: POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE)
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Can a Parent-Peer program help young adults with drug use? new study aims to find out
Knowledge-focused OngoingThis study tests a program called Launch for young adults (ages 18-26) who misuse multiple drugs and their supportive parent. The program provides peer support to the young adult and helps parents use a reward-based system at home. The goal is to see if the program is practical a…
Matched conditions: POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE)
Phase: NA • Sponsor: Chestnut Health Systems • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC